Free Trial

Cullinan Therapeutics (CGEM) SEC Filings & 10K Form

Cullinan Therapeutics logo
$12.19 -0.39 (-3.10%)
(As of 10:16 AM ET)

Recent Cullinan Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
11/12/2024
1:23 PM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/07/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
6:06 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
6:18 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
10:18 AM
Cullinan Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
11:48 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
10/16/2024
6:17 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
6:13 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:27 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Thistle Mary (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2024
6:20 AM
Cullinan Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:15 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2024
3:19 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/02/2024
6:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Ryan David P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Martin Anne-Marie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Rosenberg Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Webster Stephen W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
4:00 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
Cullinan Therapeutics (Issuer)
Ebeling Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G/A
06/04/2024
11:15 PM
Cullinan Therapeutics (Filer)
Form EFFECT
06/03/2024
7:12 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
4:07 PM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:40 PM
Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
4:30 PM
Cullinan Therapeutics (Issuer)
Meek David D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2024
6:30 AM
Cullinan Therapeutics (Filer)
Form ARS
05/16/2024
5:42 AM
Cullinan Therapeutics (Filer)
Form DEFA14A
05/16/2024
5:40 AM
Cullinan Therapeutics (Filer)
Form DEF 14A
05/08/2024
6:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2024
3:32 PM
Cullinan Therapeutics (Subject)
Michaelson Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
7:58 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2024
8:02 PM
Cullinan Therapeutics (Issuer)
Fenton Mary Kay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
6:05 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
4:50 PM
Cullinan Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G
04/16/2024
6:14 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
7:50 PM
Cullinan Therapeutics (Issuer)
Nguyen Nate (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Download Our Tesla Ebook For Free (Ad)

Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.

To claim your copy free of charge simply follow this link.
03/14/2024
6:22 AM
Cullinan Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2024
6:27 AM
Cullinan Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/14/2024
6:14 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
8:01 PM
Blue Owl Capital Holdings LP (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
02/06/2024
9:09 AM
Cullinan Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G
02/02/2024
8:35 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2024
3:43 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2024
6:00 PM
Cullinan Therapeutics (Issuer)
Savill Corrine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Cullinan Therapeutics (Subject)
Form SC 13G
01/29/2024
3:27 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2024
3:18 PM
Cullinan Therapeutics (Subject)
Savill Corrine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
3:15 PM
Cullinan Therapeutics (Filer)
Form 8-K/A
01/08/2024
8:12 AM
Cullinan Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2023
5:30 PM
AHMED NADIM (Reporting)
Cullinan Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
4:30 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
SUMER JACQUELYN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
5:00 PM
Cullinan Therapeutics (Issuer)
Jones Jeffrey Alan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:00 PM
Cullinan Therapeutics (Issuer)
Michaelson Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
7:00 PM
Cullinan Therapeutics (Issuer)
Trigilio Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CGEM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners